Latest Biotech Commercial Strategy News

Page 1 of 1

Genetic Signatures Reshapes Operations to Slash Costs and Boost Sales

Genetic Signatures is undertaking a major organisational restructure to cut costs by $5 million and sharpen its commercial focus, aiming to accelerate growth in its diagnostic product offerings.

Ada Torres

30 Mar 2026

Top